Financial Performance - Revenue for Q1 2020 was CNY 130,945,135.99, a decrease of 4.65% compared to CNY 137,327,723.12 in the same period last year[7] - Net profit attributable to shareholders was CNY 7,777,412.59, down 47.15% from CNY 14,714,968.63 year-on-year[7] - Basic and diluted earnings per share were both CNY 0.0389, reflecting a 47.15% decline from CNY 0.0736 in the same quarter last year[7] - The company reported a total comprehensive income of CNY 7,621,261.78, compared to CNY 14,639,718.94 in the same period last year[49] - Operating profit for the first quarter was CNY 11,908,204.32, down 33.5% from CNY 17,935,755.24 in the previous period[48] - The company reported a 66.03% decline in investment income to ¥574,263.17, mainly due to reduced bank wealth management products[16] - The company incurred a financial expense of CNY 1,765,667.35, slightly up from CNY 1,738,943.99[48] - The tax expense for the quarter was CNY 4,127,024.22, an increase from CNY 3,161,727.38 year-over-year[48] Cash Flow - Net cash flow from operating activities decreased by 64.54%, amounting to CNY 15,137,908.87 compared to CNY 42,686,856.38 in the previous year[7] - Cash inflow from operating activities was CNY 182,382,730.79, down from CNY 193,430,741.47 in the previous period[54] - The total cash outflow from operating activities was ¥167,244,821.92, compared to ¥150,743,885.09 in the previous year, indicating an increase of 10.5%[56] - The net cash flow from investing activities was -¥70,721,066.18, a significant decline from -¥17,367,739.98 year-over-year[56] - Cash and cash equivalents at the end of the period were ¥88,611,922.80, down from ¥97,367,844.38 at the end of the previous year[57] - The company experienced a net increase in cash and cash equivalents of -¥20,583,991.36 during the quarter, compared to -¥7,206,468.74 in the previous year[57] Assets and Liabilities - Total assets increased by 4.85% to CNY 793,193,826.04 from CNY 756,494,685.39 at the end of the previous year[7] - Current liabilities increased to CNY 164,407,476.16 from CNY 137,853,778.47, reflecting a rise of 19.2%[40] - The company’s total liabilities amounted to CNY 175,155,271.75, compared to CNY 148,271,693.97, which is an increase of 18.1%[40] - Total current assets decreased from ¥499,262,457.60 at the end of 2019 to ¥386,094,467.89, reflecting a reduction of about 22.6%[38] - The company’s total equity attributable to shareholders reached CNY 608,222,991.42, with retained earnings of CNY 115,728,694.71[68] Shareholder Information - The total number of shareholders at the end of the reporting period was 17,521[11] - The largest shareholder, Taizhou Yongjian Holding Co., Ltd., held 29.00% of the shares, amounting to 58,000,000 shares[11] Investments and Acquisitions - The company completed the acquisition of 95% equity in Dazhou Zhongke for ¥88.6 million, which will be consolidated into the financial statements[21] - The company also acquired 100% equity in Chengdu Shanshuishang Hotel for ¥126 million, which will be included in the consolidated financial statements[23] - The company completed the acquisition of 95% equity in Dazhou Zhongke Oncology Hospital Co., Ltd. on January 20, 2020[25] - The company announced the acquisition of 100% equity in Chengdu Shanshui Shang Hotel Co., Ltd. on April 2, 2020[25] Expenses - Management expenses increased by 38.48% to ¥14,397,469.35 due to new investments in the healthcare industry[16] - Research and development expenses decreased by 46.13% to ¥2,189,109.63, primarily due to reduced investment during the pandemic[16] Other Financial Information - Non-recurring gains and losses totaled CNY 584,322.06, primarily from government subsidies and investment income[8] - The company has ongoing projects in construction valued at CNY 54,177,621.74, down from CNY 60,674,830.00, indicating a decrease of 8.2%[41] - The company has a total of 1,300 million yuan in bank wealth management products, with a 3.00% annualized return[29] - The company has not reported any significant or low-security, illiquid, or non-principal-protected high-risk entrusted financial management situations[29] - The company has not disclosed any derivative investments during the reporting period[30]
永和智控(002795) - 2020 Q1 - 季度财报